SOX2 upregulates side population cells and enhances their chemoresistant ability by transactivating ABCC1 expression contributing to intrinsic resistance to paclitaxel in melanoma
出版年份 2019 全文链接
标题
SOX2 upregulates side population cells and enhances their chemoresistant ability by transactivating ABCC1 expression contributing to intrinsic resistance to paclitaxel in melanoma
作者
关键词
-
出版物
MOLECULAR CARCINOGENESIS
Volume 59, Issue 3, Pages 257-264
出版商
Wiley
发表日期
2019-12-28
DOI
10.1002/mc.23148
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Current approaches in identification and isolation of cancer stem cells
- (2019) Maryam Akbarzadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cancer cells stemness: A doorstep to targeted therapy
- (2019) Sahdeo Prasad et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Adaptive Responses as Mechanisms of Resistance to BRAF Inhibitors in Melanoma
- (2019) Saei et al. Cancers
- SP1-induced upregulation of lncRNA PANDAR predicts adverse phenotypes in retinoblastoma and regulates cell growth and apoptosis in vitro and in vivo
- (2018) Lijie Sheng et al. GENE
- Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
- (2018) Lan Thi Hanh Phi et al. Stem Cells International
- ABC transporters as cancer drivers: Potential functions in cancer development
- (2018) Alice Domenichini et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
- (2018) Lynn Roy et al. Cancers
- Cancer Stem Cells (CSCs) in melanoma: There's smoke, but is there fire?
- (2017) Constance E. Brinckerhoff JOURNAL OF CELLULAR PHYSIOLOGY
- Decreased miR-128 and increased miR-21 synergistically cause podocyte injury in sepsis
- (2017) Shanshan Wang et al. JOURNAL OF NEPHROLOGY
- Epigenetics in cancer stem cells
- (2017) Tan Boon Toh et al. Molecular Cancer
- Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells
- (2017) Pritha Mukherjee et al. Scientific Reports
- Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy
- (2016) Michael P. Smith et al. CANCER CELL
- Molecular Pathways: Maintaining MAPK Inhibitor Sensitivity by Targeting Nonmutational Tolerance
- (2016) M. P. Smith et al. CLINICAL CANCER RESEARCH
- Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors
- (2016) Gao Zhang et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
- (2016) Aaron N Hata et al. NATURE MEDICINE
- The role of ABC transporters in ovarian cancer progression and chemoresistance
- (2015) M.P. Ween et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Overcoming Multidrug Resistance in Cancer Stem Cells
- (2015) Karobi Moitra Biomed Research International
- Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells
- (2014) Harris Wang et al. BMC CANCER
- Importance of ABCC1 for cancer therapy and prognosis
- (2014) Tereza Kunická et al. DRUG METABOLISM REVIEWS
- SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells
- (2014) R Santini et al. ONCOGENE
- Tumor adaptation and resistance to RAF inhibitors
- (2013) Piro Lito et al. NATURE MEDICINE
- The Human Melanoma Side Population Displays Molecular and Functional Characteristics of Enriched Chemoresistance and Tumorigenesis
- (2013) Jasper Wouters et al. PLoS One
- Side Population Cells as Prototype of Chemoresistant, Tumor-Initiating Cells
- (2013) Vinitha Richard et al. Biomed Research International
- Side Population Cells from Human Melanoma Tumors Reveal Diverse Mechanisms for Chemoresistance
- (2012) Yuchun Luo et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- ID4 Imparts Chemoresistance and Cancer Stemness to Glioma Cells by Derepressing miR-9*-Mediated Suppression of SOX2
- (2011) H.-M. Jeon et al. CANCER RESEARCH
- Phase 3 study of docosahexaenoic acid-paclitaxel versus dacarbazine in patients with metastatic malignant melanoma
- (2010) A. Y. Bedikian et al. ANNALS OF ONCOLOGY
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
- (2010) Alexander Roesch et al. CELL
- Identification of cells initiating human melanomas
- (2008) Tobias Schatton et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now